Skip to main content
. Author manuscript; available in PMC: 2020 Oct 15.
Published in final edited form as: Stat Med. 2019 Jul 17;38(23):4503–4518. doi: 10.1002/sim.8310

Figure 5.

Figure 5.

For the pseudo-AMP trial data set by VRC01 dose group and FP visit type, boxplots of Ti*diff and 12T¯iinf.int of HIV infected cases and uninfected controls (Times Method, top panel), and of S^(Ti*) and S¯i(τ)^ (Marker Method, bottom panel). The outlier in the fifth boxplots from the left has FP visit at the Day 5 post second-infusion visit, with estimated infection time T* just before the second-infusion visit.